Research by Yanran Li and colleagues has shown that human RETN acts as a pro‐inflammatory molecule, impacting a variety of chronic inflammatory diseases, metabolic disorders, and cancers, which highlights its potential role in inflammatory pathways.26 This evidence concerns the gene RETN and metabolic disease.